Company Profile
Updated: 30-NOV-09MannKind Corp.
Public Company, Headquarters Location
28903 N Ave. Paine, Valencia, CA 91355-4169, United States
(661)775-5300, (661)775-2081 fax, http://www.mannkindcorp.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Pharmaceuticals and biopharmaceuticals.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
MANNKIND REPORTS DISPOSITION BY VP PALUMBO (California)
US Fed News Service, Including US State News; 11/11/2009; 305 words; WASHINGTON, Nov. 10 -- Mannkind Corp. (MNKD), Valencia, Calif., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...
Findings from A. Leonebay et al in obesity and diabetes reported.
Obesity & Diabetes Week; 11/9/2009; 1280 words; ...Diabetes Obesity & Metabolism, 2009;11(11):1050-1059). For more information, contact A. Leonebay, MannKind Corp., 1 Casper St., Danbury, CT 06810, USA. Publisher contact information for the journal Diabetes Obesity &...
MannKind to Present at Upcoming Conferences.(Conference news)
Health & Beauty Close-Up; 11/5/2009; 576 words; MannKind Corp., focused on discovering, developing and commercializing treatments for diabetes and cancer, announced that it will present...
MannKind Posts 3Q Financial Results.(Financial report)
Health & Beauty Close-Up; 11/5/2009; 980 words; MannKind Corp. has reported financial results for the third quarter ended September...better therapeutic option for the millions of patients with diabetes." MannKind Corp. focuses on the discovery, development and commercialization of therapeutic...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1139 words; o AmpliMed Corp., of Tucson, Ariz., said interim...endpoint of tumor response. o Genzyme Corp., of Cambridge, Mass., reported two...for the Study of Pain in Istanbul. o MannKind Corp., of Valencia, Calif., completed...
Recent News Articles
- MannKind Corporation Reports Second Quarter Financial Results.(Financial report)
Biotech Week - August 19, 2009 - News and FDA Updates for MannKind Corp (Nasdaq:MNKD), Phase Forward (NASDAQ:PFWD), Amgen (NASDAQ:AMGN), Eli Lilly (NYSE:LLY).
M2 Presswire - July 28, 2009 - MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 3, 2009.
Business Wire - July 27, 2009 - MannKind Corporation (Nasdaq:MNKD) We have picks that move!
M2 Presswire - June 09, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning